Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines

Antonio Mazzocca, Sabrina Giusti, Andrew D. Hamilton, Said M. Sebti, Pietro Pantaleo, Vinicio Carloni

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines'. Together they form a unique fingerprint.

Medicine & Life Sciences